Skip to main content

Table 2 Baseline participant characteristics according to walking intensity and duration

From: High-intensity walking in midlife is associated with improved memory in physically capable older adults

 

None

Walking intensity

Walking duration

Low

High

p

Low

High

p

n

63

68

57

 

75

50

 

Age, years

72.67 (5.23)

72.24 (5.64)

71.00 (4.34)

0.189a

72.32 (5.39)

70.70 (4.52)

0.104a

Female, no. (%)

45 (71.43)

56 (82.35)

32 (56.14)

0.060b

57 (76.00)

31 (62.00)

0.237b

Education, no. (%)

   

0.074b

  

0.071b

 ≥13 years

9 (14.29)

12 (17.65)

18 (31.58)

 

16 (21.33)

14 (28.00)

 

 10–12 years

14 (22.22)

17 (25.00)

19 (33.33)

 

20 (26.67)

16 (32.00)

 

 4–9 years

33 (52.38)

33 (48.53)

16 (28.07)

 

29 (38.67)

20 (40.00)

 

 0–3 years

7 (11.11)

6 (8.82)

4 (7.02)

 

10 (13.33)

0 (0.00)

 

MMSE

24.76 (3.80)

25.47 (3.64)

26.91 (2.19)

0.002a

25.65 (3.43)

26.84 (2.50)

0.005a

APOE4 positivity, No. (%)

13 (20.63)

16 (23.53)

8 (14.04)

0.402b

17 (22.67)

7 (14.00)

0.477b

Clinical diagnosis, CN, no. (%)

33 (52.38)

37 (54.41)

37 (64.91)

0.335b

43 (57.33)

31(62.00)

0.588b

Walking onset

   

< 0.001b

  

< 0.001b

 Midlife (40–64 years)

0 (0.00)

58 (85.29)

45 (78.95)

 

62 (82.67)

41 (82.00)

 

 Late life (≥65 years)

0 (0.00)

10 (14.71)

12 (21.05)

 

13 (17.33)

9 (18.00)

 

Annual income, no. (%)

   

0.111 b

  

0.289b

 < MCL

9 (14.29)

11 (16.18)

3 (5.26)

 

11 (14.67)

3 (6.00)

 

 ≥ MCL, < 2×MCL

23 (36.51)

22 (32.35)

14 (24.56)

 

23 (30.67)

13 (26.00)

 

 ≥ 2×MCL

31 (49.21)

35 (51.47)

40 (70.18)

 

41 (54.67)

34 (68.00)

 

VRS, %

25.40 (17.67)

22.55 (17.70)

23.68 (20.64)

0.681a

22.89 (17.28)

23.33 (21.56)

0.715a

GDS, no. (%)

   

0.067b

  

0.817b

  Normal (< 9)

29 (36.51)

28 (41.18)

35 (61.40)

 

37 (49.33)

26 (52.00)

 

  Depressed (≥10)

34 (53.97)

40 (58.82)

22 (38.60)

 

38 (50.67)

24 (48.00)

 

UPDRS, gait score (>2)

0 (0.00)

0 (0.00)

0 (0.00)

 

0 (0.00)

0 (0.00)

 

Body mass index

   

0.179c

  

0.085c

  Underweight (< 18.5)

0 (0.00)

3 (4.41)

1 (1.75)

 

4 (5.33)

0 (0.00)

 

  Normal weight (18.5–24.9)

2 (44.44)

39 (57.35)

28 (49.12)

 

39 (52.00)

28 (56.00)

 

  Overweight (≥ 25)

35(55.55)

26 (38.24)

28 (49.12)

 

32 (42.67)

22 (44.00)

 

Alcohol drink status, no (%)

   

0.832b

  

0.336b

  Never

35 (55.56)

41 (60.29)

29 (50.88)

 

46 (61.33)

24 (48.00)

 

  Former

12

10

10

 

13

7

 

  Drinker

16

17

18

 

16

19

 

PASE total score

70.73 (54.79)

61.44 (44.95)

64.76 (38.12)

0.518a

61.43 (45.67)

65.24 (35.65)

0.507a

Blood markers

 Hemoglobin

13.25 (1.60)

13.10 (1.58)

13.70 (1.31)

0.081a

13.38 (1.53)

13.37 (1.52)

0.865a

 Albumin

4.57 (0.26)

4.57 (0.24)

4.59 (0.29)

0.898a

4.56 (0.24)

4.60 (0.29)

0.775a

 Glucose, fasting

108.34 (17.76)

107.56 (21.24)

109.50 (22.04)

0.870a

108.31 (22.37)

108.62 (20.47)

0.996a

 HDL-cholesterol

53.58 (13.61)

55.59 (13.61)

55.43 (11.24)

0.629a

55.20 (12.40)

55.98 (12.86)

0.598a

 LDL-cholesterol

98.21 (34.64)

97.50 (34.01)

92.18 (31.45)

0.568a

96.34 (33.49)

93.26 (32.13)

0.738a

Nutritional markers

 Protein, no (%)

   

0.119b

  

0.475b

  High

6 (9.52)

6 (13.24)

13 (22.81)

 

10 (13.33)

9 (18.00)

 

  Moderate

23 (36.51)

28 (41.18)

22 (38.60)

 

28 (37.33)

22 (44.00)

 

  Low

34 (53.97)

34 (51.47)

22 (38.60)

 

37 (49.33)

19 (38.00)

 

 Fruit and Vegetables, no (%)

   

0.689b

  

0.147b

  High

43 (68.25)

44 (64.71)

41 (71.93)

 

46 (61.33)

39 (78.00)

 

  Low

20 (31.75)

24 (35.29)

16 (28.07)

 

29 (38.67)

11 (22.00)

 

Decrease in food intake over the past 3 months, No (%)

6 (9.52)

4 (5.88)

4 (7.02)

0.722c

5 (6.67)

3 (6.00)

0.736c

CERAD cognition

 Total score

65.21 (14.48)

68.38 (14.40)

78.88 (14.51)

< 0.001a

71.29(15.85)

75.98 (14.17)

< 0.001a

 Memory score

32.56 (9.62)

35.01 (9.77)

39.18 (7.00)

< 0.001a

36.20 (9.72)

37.98 (7.25)

0.005a

 Non-memory score

33.05 (6.56)

33.18 (6.33)

37.33 (6.22)

< 0.001a

34.12 (6.99)

36.50 (5.73)

0.020a

  1. Data are expressed as mean (standard deviation), unless otherwise indicated
  2. MMSE mini-mental status examination, APOE4 apolipoprotein ε4, CN cognitively normal, MCL minimum cost of living, VRS vascular risk score, GDS geriatric depression scale, UPDRS Unified Parkinson’s Disease Rating Scale, PASE physical activity scale for the elderly, CERAD Consortium to Establish a Registry for Alzheimer’s Disease
  3. aBy one-way analysis of variance
  4. bBy chi-square test
  5. cBy Fisher exact test